An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma

@inproceedings{Xu2017AnII,
  title={An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma},
  author={Yi Xu and Yanyue Tong and Jianyong Zhu and Zhangming Lei and Lijun Wan and Xiuwen Zhu and Feng Ye and Li-Ping Xie},
  booktitle={BMC Cancer},
  year={2017}
}
Nearly 30% of clear cell renal cell carcinoma (ccRCC) patients present with metastasis at the time of diagnosis, and the prognosis for these patients is poor. Therefore, novel potential prognostic biomarkers and therapeutic targets for ccRCC could be helpful. Emerging evidence indicates that lncRNAs play important roles in cancer tumorigenesis and could be used as potential biomarkers or therapeutic targets. PANDAR (promoter of CDKN1A antisense DNA damage activated RNA) is a relatively novel… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 29 references

ESMO Clinical Xu et al

B Escudier, C Porta, +6 authors carcinoma Committee EG. Renal cell
BMC Cancer • 2017
View 1 Excerpt

tumour resistance to apoptosis

FH Igney, Krammer PH. Death, anti-death
Nat Rev Cancer. 2002;2:277–88. • We accept pre-submission inquiries • Our selector tool helps you to find the most relevant journal • We provide round the clock customer support • Convenient online submission • Thorough peer review • Inclusion in PubMed and all major indexing services • Maximum visi • 2017
View 1 Excerpt

Anti-tumor effects of Atractylenolide I on bladder cancer cells

Rui Yu, Bi-xia Yu, +4 authors Qi Ma
Journal of experimental & clinical cancer research : CR • 2016
View 1 Excerpt

Similar Papers

Loading similar papers…